Forbes on how GLP-1 travelers are changing hotels, menus and wellness trips

More peptides

1. ABC's Dr. Tara Narula explains Novo's new GLP-1 and how it differs from others

   

   FFacebook Oct 20

   peptides typeshitNews

   ABC's Dr. Tara Narula explains Novo's new GLP-1 and how it differs from others

   ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.

   See it on Facebook
2. Investseekers looks at Novo's Oral Wegovy launch in France and beyond

   

   IInvestseekers Oct 20

   peptides typeshitNews

   Investseekers looks at Novo's Oral Wegovy launch in France and beyond

   Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.

   See it on X
3. A creator on how much there is to track on a GLP-1, from shots to protein

   Y@yuechuang8803 Oct 20

   peptides typeshitNews

   A creator on how much there is to track on a GLP-1, from shots to protein

   A short social clip runs through the daily checklist of a GLP-1 routine: injections, water, protein and keeping tabs on progress.

   Watch on TikTok
4. Dr. Rekha Kumar on what to focus on during your first month on a GLP-1

   

   D@drrekhakumar Oct 20

   peptides typeshitNews

   Dr. Rekha Kumar on what to focus on during your first month on a GLP-1

   Kumar says month one is less about big drops on the scale and more about setting up habits that help the medication work over time.

   See it on Instagram
5. Report says a new class of weight loss drugs outperforms Ozempic

   ?ΕΜΥ Oct 20

   peptides typeshitResearch

   Report says a new class of weight loss drugs outperforms Ozempic

   A short item claims a newer group of weight loss drugs beats Ozempic, without naming the drugs or the data behind the claim.

   Read at ΕΜΥ
6. Dr. Linda Zheng flags NAION vision loss risk tied to Ozempic and Mounjaro

   D@drlindazheng Oct 20

   peptides typeshitSafety

   Dr. Linda Zheng flags NAION vision loss risk tied to Ozempic and Mounjaro

   Dr. Zheng says the drugs have been associated with NAION, an eye condition that can cause permanent vision loss, and points to patients with risk factors.

   Watch on TikTok